Philips’ broad portfolio of imaging and measurement catheters
combined with its leading interventional imaging solutions provide a
comprehensive solution with the aim to enhance procedural outcomes
Company Website:
http://www.philips.ca
MARKHAM, Ontario -- (Business Wire)
Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has
incorporated its Volcano catheter-based imaging and measurement
solutions for minimally invasive diagnostics and treatment of
cardiovascular and other disease, into its robust portfolio of
interventional cardiology solutions in Canada.
“We are committed to delivering innovative solutions for our customers
in Canada and the patients they serve,” said Iain Burns, President and
CEO of Philips Canada. “The inclusion of our Volcano products will
provide our customers with better access to all of the integrated
technologies and specialized expertise across Philips’ entire Image
Guided Therapy portfolio. Offering our customers these integrated
solutions helps us achieve our goal of equipping them with tools that
can improve their patients’ care.”
Philips has an existing rich portfolio of interventional imaging
equipment, navigation tools and services, and a sizeable customer base,
including 85% of Canadian hospitals who have chosen Philips cardiology
solutions. Philips’ advanced interventional imaging systems and
navigation tools provide the visual maps that allow the clinician to
guide thin, tube-shaped instruments called catheters through the body to
the area of interest and perform the minimally invasive treatment. In
image-guided treatments of the heart and blood vessels, there is
increased clinical evidence which demonstrates that the use of imaging
and measurement catheters in conjunction with interventional x-ray
imaging helps improve procedural outcomes.
Through its Volcano product portfolio, Philips is a world leader in
catheter-based imaging and measurements like IVUS (Intravascular
Ultrasound) catheters that are capable of producing ultrasound images of
the interior blood vessels and FFR/iFR (Fraction Flow Reserve)
technologies that are used to assess the blood pressure. These solutions
complement Philips’ portfolio of interventional x-ray and ultrasound
imaging equipment, navigation systems, software and services; together
they enable confident diagnosis and treatment.
To learn more about Philips’ Image Guided Therapy solutions click here
or visit Philips Canada at the Canadian
Cardiovascular Congress in Montreal, Quebec from October 22nd
to October 25th.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is
a leading health technology company focused on improving people’s health
and enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer insights to
deliver integrated solutions. Headquartered in the Netherlands, the
company is a leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health and
home care. Philips’ health technology portfolio generated 2015 sales of
EUR 16.8 billion and employs approximately 69,000 employees with sales
and services in more than 100 countries. News about Philips can be found
at www.philips.com/newscenter.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161004005314/en/
Contacts:
Philips Canada
Santina Giuliano, 905-201-4196
Communications
Manager
santina.giuliano@philips.com
Source: Royal Philips
© 2024 Canjex Publishing Ltd. All rights reserved.